BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, Naliboff BD. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20:89-97. [PMID: 15225175 DOI: 10.1111/j.1365-2036.2004.02007.x] [Cited by in Crossref: 263] [Cited by in F6Publishing: 252] [Article Influence: 14.6] [Reference Citation Analysis]
Number Citing Articles
1 Sugaya N, Tomita Y, Funaba M, Iida H, Shirotsuki K, Gardner FC, Odawara T, Ando T, Inamori M. Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome. BioPsychoSocial Med 2022;16. [DOI: 10.1186/s13030-022-00244-3] [Reference Citation Analysis]
2 Cusack CE, Ralph-nearman C, Nicholas JK, Levinson CA. New directions in research on somatic concerns in individuals with eating disorders. New Ideas in Psychology 2022;66:100937. [DOI: 10.1016/j.newideapsych.2022.100937] [Reference Citation Analysis]
3 Brown C, Dunn W. Development of a Participation Focused Measure of Interoception for Adults. OTJR (Thorofare N J) 2022;:15394492221112651. [PMID: 35899311 DOI: 10.1177/15394492221112651] [Reference Citation Analysis]
4 Staller K, Paz M, Rones R, Macklin EA, Garcia-Fischer I, Murray HB, Kuo B. Virtual Tai Chi program for patients with irritable bowel syndrome with constipation: Proof-of-concept feasibility trial. Neurogastroenterol Motil 2022;:e14429. [PMID: 35833716 DOI: 10.1111/nmo.14429] [Reference Citation Analysis]
5 Goodoory VC, Ng CE, Black CJ, Ford AC. Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living. Aliment Pharmacol Ther 2022. [PMID: 35794733 DOI: 10.1111/apt.17132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Biesiekierski JR, Manning LP, Murray HB, Vlaeyen JWS, Ljótsson B, Van Oudenhove L. Review article: Exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome. Aliment Pharmacol Ther 2022. [PMID: 35775328 DOI: 10.1111/apt.17111] [Reference Citation Analysis]
7 Goodoory VC, Ng CE, Black CJ, Ford AC. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Aliment Pharmacol Ther 2022;56:110-20. [PMID: 35491477 DOI: 10.1111/apt.16939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Lövdahl J, Törnblom H, Ringström G, Palsson OS, Simrén M. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome. Aliment Pharmacol Ther 2022;55:1501-11. [PMID: 35505463 DOI: 10.1111/apt.16934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Black CJ, Ford AC. Letter in response to Black et al. (2020): Authors' Reply. Neurogastroenterol Motil 2022;34:e14388. [PMID: 35468248 DOI: 10.1111/nmo.14388] [Reference Citation Analysis]
10 Lalouni M, Olén O, Bjureberg J, Bonnert M, Chalder T, Hedman-Lagerlöf E, Reme SE, Serlachius E, Ljótsson B. Validation of child-adapted short scales for measuring gastrointestinal-specific avoidance and anxiety. Acta Paediatr 2022. [PMID: 35545865 DOI: 10.1111/apa.16403] [Reference Citation Analysis]
11 Atanasova K, Lotter T, Bekrater-Bodmann R, Kleindienst N, Reindl W, Lis S. Is It a Gut Feeling? Bodily Sensations Associated With the Experience of Valence and Arousal in Patients With Inflammatory Bowel Disease. Front Psychiatry 2022;13:833423. [PMID: 35530019 DOI: 10.3389/fpsyt.2022.833423] [Reference Citation Analysis]
12 Black CJ, Houghton LA, Ford AC. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities. Neurogastroenterol Motil 2022;:e14391. [PMID: 35531932 DOI: 10.1111/nmo.14391] [Reference Citation Analysis]
13 Trieschmann K, Chang L, Park S, Naliboff B, Joshi S, Labus JS, Sauk JS, Limketkai BN, Mayer EA. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease. Neurogastroenterol Motil 2022;:e14384. [PMID: 35478469 DOI: 10.1111/nmo.14384] [Reference Citation Analysis]
14 Wallén H, Ljótsson B, Svanborg C, Rydh S, Falk L, Lindfors P. Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic - a clinical effectiveness study. Scand J Gastroenterol 2022;:1-8. [PMID: 35260030 DOI: 10.1080/00365521.2022.2047220] [Reference Citation Analysis]
15 Goodoory VC, Ng CE, Black CJ, Ford AC. Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Aliment Pharmacol Ther 2022. [PMID: 35166374 DOI: 10.1111/apt.16816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Farrukh A. Measurement of Pain and Related Symptoms in Irritable Bowel Syndrome: The Use of Validated Pain Measurement Tools. Gastrointestinal Disorders 2022;4:22-9. [DOI: 10.3390/gidisord4010004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Trindade IA, Melchior C, Colomier E, Algera J, Törnblom H, Simrén M. Letter in response to Black et al. (2020). Neurogastroenterol Motil 2022;:e14329. [PMID: 35107195 DOI: 10.1111/nmo.14329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hunt MG, Dalvie A, Ipek S, Wasman B. Acceptability and efficacy of the Zemedy app versus a relaxation training and meditation app for IBS: protocol for a randomised controlled trial. BMJ Open 2022;12:e055014. [PMID: 35039299 DOI: 10.1136/bmjopen-2021-055014] [Reference Citation Analysis]
19 Nybacka S, Törnblom H, Simren M, Störsrud S. The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options. JMIR Res Protoc 2022;11:e31413. [PMID: 35037893 DOI: 10.2196/31413] [Reference Citation Analysis]
20 Colomier E, Van Oudenhove L, Tack J, Böhn L, Bennet S, Nybacka S, Störsrud S, Öhman L, Törnblom H, Simrén M. Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome. Nutrients 2022;14:397. [PMID: 35057578 DOI: 10.3390/nu14020397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Poovey K, Ahlich E, Attaway S, Rancourt D. General versus hunger/satiety-specific interoceptive sensibility in predicting disordered eating. Appetite 2022;:105930. [PMID: 35033582 DOI: 10.1016/j.appet.2022.105930] [Reference Citation Analysis]
22 Segna D, Jaklin PJ, Schnüriger B, Misselwitz B. Health-related quality of life and functional disorders after diverticular surgery. Therap Adv Gastroenterol 2021;14:17562848211066437. [PMID: 34987613 DOI: 10.1177/17562848211066437] [Reference Citation Analysis]
23 Keefer L, Bedell A, Norton C, Hart AL. How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease? Gastroenterology 2022:S0016-5085(21)04073-7. [PMID: 34995528 DOI: 10.1053/j.gastro.2021.08.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
24 Sugaya N, Shirotsuki K, Nakao M. Cognitive behavioral treatment for irritable bowel syndrome: a recent literature review. Biopsychosoc Med 2021;15:23. [PMID: 34838129 DOI: 10.1186/s13030-021-00226-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Luo Y, Keefer L. Role of psychological questionnaires in clinical practice and research within functional gastrointestinal disorders. Neurogastroenterol Motil 2021;33:e14297. [PMID: 34786802 DOI: 10.1111/nmo.14297] [Reference Citation Analysis]
26 Zickgraf HF, Loftus P, Gibbons B, Cohen LC, Hunt MG. "If I could survive without eating, it would be a huge relief": Development and initial validation of the Fear of Food Questionnaire. Appetite 2021;:105808. [PMID: 34798226 DOI: 10.1016/j.appet.2021.105808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Möller SP, Apputhurai P, Tye-Din JA, Knowles SR. Quality of life in coeliac disease: relationship between psychosocial processes and quality of life in a sample of 1697 adults living with coeliac disease. J Psychosom Res 2021;151:110652. [PMID: 34739942 DOI: 10.1016/j.jpsychores.2021.110652] [Reference Citation Analysis]
28 Peters JE, Basnayake C, Hebbard GS, Salzberg MR, Kamm MA. Prevalence of disordered eating in adults with gastrointestinal disorders: A systematic review. Neurogastroenterol Motil 2021;:e14278. [PMID: 34618988 DOI: 10.1111/nmo.14278] [Reference Citation Analysis]
29 Funaba M, Kawanishi H, Fujii Y, Higami K, Tomita Y, Maruo K, Sugawara N, Oe Y, Kura S, Horikoshi M, Ohara C, Kikuchi H, Ariga H, Fukudo S, Sekiguchi A, Ando T. Hybrid Cognitive Behavioral Therapy With Interoceptive Exposure for Irritable Bowel Syndrome: A Feasibility Study. Front Psychiatry 2021;12:673939. [PMID: 34566709 DOI: 10.3389/fpsyt.2021.673939] [Reference Citation Analysis]
30 Algera JP, Störsrud S, Lindström A, Simrén M, Törnblom H. Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clin Nutr 2021;40:5365-72. [PMID: 34560607 DOI: 10.1016/j.clnu.2021.09.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Keefer L, Ballou SK, Drossman DA, Ringstrom G, Elsenbruch S, Ljótsson B. A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction. Gastroenterology 2022;162:300-15. [PMID: 34529986 DOI: 10.1053/j.gastro.2021.09.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
32 Goodoory VC, Houghton LA, Black CJ, Ford AC. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterol Motil 2021;:e14268. [PMID: 34532930 DOI: 10.1111/nmo.14268] [Reference Citation Analysis]
33 Vork L, Keszthelyi D, van Kuijk SMJ, Quetglas EG, Törnblom H, Simrén M, Aziz Q, Corsetti M, Tack J, Mujagic Z, Leue C, Kruimel JW, Masclee AAM. Patient-Specific Stress-Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study. Clin Transl Gastroenterol 2020;11:e00209. [PMID: 32764210 DOI: 10.14309/ctg.0000000000000209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Norton C, Syred J, Kerry S, Artom M, Sweeney L, Hart A, Czuber-Dochan W, Taylor SJC, Mihaylova B, Roukas C, Aziz Q, Miller L, Pollok R, Saxena S, Stagg I, Terry H, Zenasni Z, Dibley L, Moss-Morris R. Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial. Trials 2021;22:516. [PMID: 34344432 DOI: 10.1186/s13063-021-05466-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wallén H, Lindfors P, Andersson E, Hedman-Lagerlöf E, Hesser H, Lindefors N, Svanborg C, Ljótsson B. Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial. BMC Gastroenterol 2021;21:289. [PMID: 34256715 DOI: 10.1186/s12876-021-01867-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Lackner JM, Quigley BM, Radziwon CD, Vargovich AM. IBS Patients' Treatment Expectancy and Motivation Impacts Quality of the Therapeutic Alliance With Provider: Results of the IBS Outcome Study. J Clin Gastroenterol 2021;55:411-21. [PMID: 32301832 DOI: 10.1097/MCG.0000000000001343] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Melchior C, Algera J, Colomier E, Törnblom H, Simrén M, Störsrud S. Food Avoidance and Restriction in Irritable Bowel Syndrome: Relevance for Symptoms, Quality of Life and Nutrient Intake. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00715-1. [PMID: 34229035 DOI: 10.1016/j.cgh.2021.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
38 Yan R, Murphy M, Genoni A, Marlow E, Dunican IC, Lo J, Andrew L, Devine A, Christophersen CT. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.BMJ Open Gastroenterol. 2020;7. [PMID: 32816830 DOI: 10.1136/bmjgast-2020-000448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Atanasova K, Lotter T, Reindl W, Lis S. Multidimensional Assessment of Interoceptive Abilities, Emotion Processing and the Role of Early Life Stress in Inflammatory Bowel Diseases. Front Psychiatry 2021;12:680878. [PMID: 34248716 DOI: 10.3389/fpsyt.2021.680878] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Losa M, Manz SM, Schindler V, Savarino E, Pohl D. Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease. Neurogastroenterol Motil 2021;33:e14177. [PMID: 34128293 DOI: 10.1111/nmo.14177] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Schindler V, Giezendanner S, Van Oudenhove L, Murray FR, Buehler J, Bordier V, Hente J, Pohl D. Better response to low FODMAP diet in disorders of gut-brain interaction patients with pronounced hydrogen response to a nutrient challenge test. J Gastroenterol Hepatol 2021. [PMID: 34107550 DOI: 10.1111/jgh.15573] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
42 Pacheco-Carroza EA. Visceral pain, mechanisms, and implications in musculoskeletal clinical practice. Med Hypotheses 2021;153:110624. [PMID: 34126503 DOI: 10.1016/j.mehy.2021.110624] [Reference Citation Analysis]
43 Eugenicos MP, Ferreira NB. Psychological factors associated with inflammatory bowel disease. Br Med Bull 2021;138:16-28. [PMID: 34057462 DOI: 10.1093/bmb/ldab010] [Reference Citation Analysis]
44 Hunt MG, Loftus P, Accardo M, Keenan M, Cohen L, Osterman MT. Self-help Cognitive Behavioral Therapy Improves Health-Related Quality of Life for Inflammatory Bowel Disease Patients: A Randomized Controlled Effectiveness Trial. J Clin Psychol Med Settings 2020;27:467-79. [PMID: 31025253 DOI: 10.1007/s10880-019-09621-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
45 Lenhart A, Dong T, Joshi S, Jaffe N, Choo C, Liu C, Jacobs JP, Lagishetty V, Shih W, Labus JS, Gupta A, Tillisch K, Mayer EA, Chang L. Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00565-6. [PMID: 34022450 DOI: 10.1016/j.cgh.2021.05.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
46 Hunt M, Miguez S, Dukas B, Onwude O, White S. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial. JMIR Mhealth Uhealth 2021;9:e26152. [PMID: 33872182 DOI: 10.2196/26152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wildes JE, Bedell A, Graham AK, Kells M. Brain-gut psychotherapies: Promising tools to address gastrointestinal problems in patients with eating disorders. Int J Eat Disord 2021;54:1063-7. [PMID: 34013611 DOI: 10.1002/eat.23555] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Ju T, Naliboff BD, Shih W, Presson AP, Liu C, Gupta A, Mayer EA, Chang L. Risk and Protective Factors Related to Early Adverse Life Events in Irritable Bowel Syndrome. J Clin Gastroenterol 2020;54:63-9. [PMID: 30575634 DOI: 10.1097/MCG.0000000000001153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
49 Hesser H, Hedman-Lagerlöf E, Lindfors P, Andersson E, Ljótsson B. Behavioral avoidance moderates the effect of exposure therapy for irritable bowel syndrome: A secondary analysis of results from a randomized component trial. Behav Res Ther 2021;141:103862. [PMID: 33895547 DOI: 10.1016/j.brat.2021.103862] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
50 Sweeney L, Moss-Morris R, Czuber-Dochan W, Norton C. Pain management in inflammatory bowel disease: feasibility of an online therapist-supported CBT-based self-management intervention. Pilot Feasibility Stud 2021;7:95. [PMID: 33863398 DOI: 10.1186/s40814-021-00829-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:1485-94. [PMID: 33840729 DOI: 10.14309/ajg.0000000000001247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhou WC, Jia L, Deng Q, Wen YG, Shang DW, Ni XJ, Huang YX, Liu Y, Zhao HB, Yang M, Dou GY. Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome. Dig Liver Dis 2021;53:1422-7. [PMID: 33753003 DOI: 10.1016/j.dld.2021.02.020] [Reference Citation Analysis]
53 Owusu JT, Sibelli A, Moss-Morris R, van Tilburg MAL, Levy RL, Oser M. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome. Neurogastroenterol Motil 2021;33:e14108. [PMID: 33745228 DOI: 10.1111/nmo.14108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Roman S, Guadagnoli LA, Hastier A, Becam E, Craven MRA, Napoléon M, Pandolfino JE, Carlson DA, Mion F, Taft T. Validation of the French version of the esophageal hypervigilance and anxiety scale. Clin Res Hepatol Gastroenterol 2021;45:101672. [PMID: 33722776 DOI: 10.1016/j.clinre.2021.101672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Berens S, Schaefert R, Ehrenthal JC, Baumeister D, Gauss A, Eich W, Tesarz J. The Validity of Somatic Symptom Disorder in Patients With Gastrointestinal Complaints. J Clin Gastroenterol 2021;55:e66-76. [PMID: 33780221 DOI: 10.1097/MCG.0000000000001505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Polster A, Öhman L, Tap J, Derrien M, Le Nevé B, Sundin J, Törnblom H, Cvijovic M, Simrén M. A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome. Sci Rep 2021;11:5521. [PMID: 33750831 DOI: 10.1038/s41598-021-84686-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Turkiewicz J, Bhatt RR, Wang H, Vora P, Krause B, Sauk JS, Jacobs JP, Bernstein CN, Kornelsen J, Labus JS, Gupta A, Mayer EA. Altered brain structural connectivity in patients with longstanding gut inflammation is correlated with psychological symptoms and disease duration. Neuroimage Clin 2021;30:102613. [PMID: 33823388 DOI: 10.1016/j.nicl.2021.102613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA, Ford AC. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. Am J Gastroenterol 2021;116:372-81. [PMID: 33110014 DOI: 10.14309/ajg.0000000000000975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
59 Brown TA, Reilly EE, Murray HB, Perry TR, Kaye WH, Wierenga CE. Validating the visceral sensitivity index in an eating disorder sample. Int J Eat Disord 2021;54:986-94. [PMID: 33448442 DOI: 10.1002/eat.23471] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
60 Nybacka S, Störsrud S, Lindqvist HM, Törnblom H, Simrén M, Winkvist A. Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome. Nutrients 2020;13:E27. [PMID: 33374779 DOI: 10.3390/nu13010027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 De Petrillo A, Hughes LD, McGuinness S, Roberts D, Godfrey E. A systematic review of psychological, clinical and psychosocial correlates of perceived food intolerance. J Psychosom Res 2021;141:110344. [PMID: 33383523 DOI: 10.1016/j.jpsychores.2020.110344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2020; 26(45): 7153-7172 [PMID: 33362374 DOI: 10.3748/wjg.v26.i45.7153] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
63 Ferreira NB, Gillanders D, Morris PG, Eugenicos M. Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change. Clinical Psychologist 2018;22:241-50. [DOI: 10.1111/cp.12123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
64 Midenfjord I, Borg A, Törnblom H, Simrén M. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:769-79. [DOI: 10.14309/ajg.0000000000001038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
65 Lalouni M, Hesser H, Bonnert M, Hedman-Lagerlöf E, Serlachius E, Olén O, Ljótsson B. Breaking the vicious circle of fear and avoidance in children with abdominal pain: A mediation analysis. J Psychosom Res 2021;140:110287. [PMID: 33227558 DOI: 10.1016/j.jpsychores.2020.110287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
66 Berentsen B, Nagaraja BH, Teige EP, Lied GA, Lundervold AJ, Lundervold K, Steinsvik EK, Hillestad ER, Valeur J, Brønstad I, Gilja OH, Osnes B, Hatlebakk JG, Haász J, Labus J, Gupta A, Mayer EA, Benitez-Páez A, Sanz Y, Lundervold A, Hausken T. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome. Medicine (Baltimore) 2020;99:e21950. [PMID: 32925728 DOI: 10.1097/MD.0000000000021950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
67 Addante R, Naliboff B, Shih W, Presson AP, Tillisch K, Mayer EA, Chang L. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals. J Clin Gastroenterol. 2019;53:e142-e149. [PMID: 29351154 DOI: 10.1097/mcg.0000000000000978] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
68 Bednarska O, Icenhour A, Tapper S, Witt ST, Tisell A, Lundberg P, Elsenbruch S, Engström M, Walter S. Reduced excitatory neurotransmitter levels in anterior insulae are associated with abdominal pain in irritable bowel syndrome. Pain 2019;160:2004-12. [PMID: 31045748 DOI: 10.1097/j.pain.0000000000001589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
69 Christensen K, Ostersen LH, Glavind K, Krarup AL, Kjærgaard N. Acute colonic pseudo-obstruction after cesarean section and gastrointestinal symptoms⋆. Eur J Obstet Gynecol Reprod Biol 2020;252:418-23. [PMID: 32721839 DOI: 10.1016/j.ejogrb.2020.06.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Wright CD, Nelson CI, Brumbaugh JT, McNeil DW. The Role of Distress Tolerance as a Potential Mechanism Between Anxiety Sensitivity and Gut-Specific Anxiety. Int J Behav Med 2020;27:717-25. [PMID: 32583317 DOI: 10.1007/s12529-020-09912-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Rahal H, Videlock EJ, Icenhour A, Shih W, Naliboff B, Gupta A, Mayer EA, Chang L. Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events. Neurogastroenterol Motil 2020;32:e13896. [PMID: 32558017 DOI: 10.1111/nmo.13896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
72 Yu L, Inspector Y, McCracken LM. Preliminary investigation of the associations between psychological flexibility, symptoms and daily functioning in people with chronic abdominal pain. Br J Pain 2021;15:175-86. [PMID: 34055339 DOI: 10.1177/2049463720926559] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Khalighi Sikaroudi M, Mokhtare M, Shidfar F, Janani L, Faghihi Kashani A, Masoodi M, Agah S, Dehnad A, Shidfar S. Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial. EXCLI J 2020;19:652-67. [PMID: 33013260 DOI: 10.17179/excli2020-2247] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
74 Black CJ, Yiannakou Y, Houghton LA, Shuweihdi F, West R, Guthrie E, Ford AC. Anxiety‐related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13872] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
75 Ruchkina IN, Vyaznikova AA, Indeykina LK, Degterev DA, Parfenov AI. [Multidisciplinary treatment of the patient with a severe irritable bowel syndrome]. Ter Arkh 2020;92:81-4. [PMID: 32598723 DOI: 10.26442/00403660.2020.02.000523] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Ballou S, Lembo A. Editorial: symptom improvement does not equal satisfaction with treatment for constipation. Aliment Pharmacol Ther 2020;51:909-10. [DOI: 10.1111/apt.15683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
77 Lindfors P, Axelsson E, Engstrand K, Störsrud S, Jerlstad P, Törnblom H, Ljótsson B, Simrén M, Ringström G. Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial. Clin Gastroenterol Hepatol 2021;19:743-751.e1. [PMID: 32289541 DOI: 10.1016/j.cgh.2020.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Naliboff BD, Smith SR, Serpa JG, Laird KT, Stains J, Connolly LS, Labus JS, Tillisch K. Mindfulness‐based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
79 Bowers H, Gillanders D, Ferreira N. Moderating effect of IBS acceptance on psychosocial mediators of Irritable Bowel Syndrome. Journal of Contextual Behavioral Science 2020;16:30-6. [DOI: 10.1016/j.jcbs.2020.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Björkman I, Ringström G, Simrén M, Myrgren J, Jakobsson Ung E. An Intervention for Person-Centered Support in Irritable Bowel Syndrome: Development and Pilot Study. Gastroenterol Nurs 2019;42:332-41. [PMID: 31365423 DOI: 10.1097/SGA.0000000000000378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Ballou S, Katon J, Rangan V, Cheng V, Nee J, Iturrino J, Lembo A. Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig Dis Sci 2020;65:3260-70. [DOI: 10.1007/s10620-020-06182-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
82 Mion F, Pellissier S, Garros A, Damon H, Roman S, Bonaz B. Transcutaneous auricular vagus nerve stimulation for the treatment of irritable bowel syndrome: a pilot, open-label study. Bioelectronics in Medicine 2020;3:5-12. [DOI: 10.2217/bem-2020-0004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
83 Clevers E, Nordqvist A, Törnblom H, Tack J, Masclee A, Keszthelyi D, Van Oudenhove L, Simrén M. Food-symptom diaries can generate personalized lifestyle advice for managing gastrointestinal symptoms: A pilot study. Neurogastroenterol Motil 2020;32:e13820. [PMID: 32031756 DOI: 10.1111/nmo.13820] [Reference Citation Analysis]
84 Steinsvik EK, Valeur J, Hausken T, Gilja OH. Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors. J Neurogastroenterol Motil 2020;26:96-105. [PMID: 31917915 DOI: 10.5056/jnm19072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
85 Murray HB, Flanagan R, Banashefski B, Silvernale CJ, Kuo B, Staller K. Frequency of Eating Disorder Pathology Among Patients With Chronic Constipation and Contribution of Gastrointestinal-Specific Anxiety. Clin Gastroenterol Hepatol. 2020;18:2471-2478. [PMID: 31923640 DOI: 10.1016/j.cgh.2019.12.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
86 Wright CD, Tiani AG, Billingsley AL, Steinman SA, Larkin KT, McNeil DW. A Framework for Understanding the Role of Psychological Processes in Disease Development, Maintenance, and Treatment: The 3P-Disease Model. Front Psychol 2019;10:2498. [PMID: 31824367 DOI: 10.3389/fpsyg.2019.02498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
87 Zhang WX, Zhang Y, Qin G, Li KM, Wei W, Li SY, Yao SK. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2019; 25(43): 6416-6429 [PMID: 31798278 DOI: 10.3748/wjg.v25.i43.6416] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
88 Quigley BM, Sova CC, Brenner DM, Keefer LA, Sitrin MD, Radziwon CD, Krasner SS, Lackner JM. (Can't Get No) Patient Satisfaction: The Predictive Power of Demographic, GI, and Psychological Factors in IBS Patients. J Clin Gastroenterol 2018;52:614-21. [PMID: 28787357 DOI: 10.1097/MCG.0000000000000906] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
89 Masuy I, Carbone F, Holvoet L, Vandenberghe A, Vanuytsel T, Tack J. The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population. Neurogastroenterol Motil 2020;32:e13739. [PMID: 31608532 DOI: 10.1111/nmo.13739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lalouni M, Ljótsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, Högström J, Sahlin H, Simrén M, Feldman I, Hedman-lagerlöf E, Serlachius E, Olén O. Clinical and Cost Effectiveness of Online Cognitive Behavioral Therapy in Children With Functional Abdominal Pain Disorders. Clinical Gastroenterology and Hepatology 2019;17:2236-2244.e11. [DOI: 10.1016/j.cgh.2018.11.043] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
91 Icenhour A, Tapper S, Bednarska O, Witt ST, Tisell A, Lundberg P, Elsenbruch S, Walter S. Elucidating the putative link between prefrontal neurotransmission, functional connectivity, and affective symptoms in irritable bowel syndrome. Sci Rep 2019;9:13590. [PMID: 31537890 DOI: 10.1038/s41598-019-50024-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
92 Larussa T, Suraci E, Marasco R, Imeneo M, Abenavoli L, Luzza F. Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization. Medicina (Kaunas) 2019;55:E507. [PMID: 31434334 DOI: 10.3390/medicina55080507] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
93 Kawanishi H, Sekiguchi A, Funaba M, Fujii Y, Yoshiuchi K, Kikuchi H, Kawai K, Maruo K, Sugawara N, Hatano K, Shoji T, Yamazaki T, Toda K, Murakami M, Shoji M, Ohara C, Tomita Y, Fukudo S, Ando T. Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan. Biopsychosoc Med 2019;13:14. [PMID: 31178921 DOI: 10.1186/s13030-019-0155-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Black CJ, Yiannakou Y, Houghton LA, Ford AC. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clin Gastroenterol Hepatol 2020;18:392-398.e2. [PMID: 31154027 DOI: 10.1016/j.cgh.2019.05.037] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 15.3] [Reference Citation Analysis]
95 Weerts ZZRM, Vork L, Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, Leue C, Muris JWM, Jonkers DMAE, Masclee AAM. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterol Motil 2019;31:e13629. [PMID: 31119844 DOI: 10.1111/nmo.13629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
96 Khoury NM, Lutz J, Schuman-Olivier Z. Interoception in Psychiatric Disorders: A Review of Randomized, Controlled Trials with Interoception-Based Interventions. Harv Rev Psychiatry 2018;26:250-63. [PMID: 30188337 DOI: 10.1097/HRP.0000000000000170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
97 Midenfjord I, Polster A, Sjövall H, Törnblom H, Simrén M. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13619] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 7.7] [Reference Citation Analysis]
98 Josefsson A, Rosendahl A, Jerlstad P, Näslin G, Törnblom H, Simrén M. Visceral sensitivity remains stable over time in patients with irritable bowel syndrome, but with individual fluctuations. Neurogastroenterol Motil 2019;31:e13603. [PMID: 31012215 DOI: 10.1111/nmo.13603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
99 Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2019; 25(2): 269-281 [PMID: 30670915 DOI: 10.3748/wjg.v25.i2.269] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
100 Bonnert M, Olén O, Lalouni M, Hedman-lagerlöf E, Särnholm J, Serlachius E, Ljótsson B. Internet-Delivered Exposure-Based Cognitive-Behavioral Therapy for Adolescents With Functional Abdominal Pain or Functional Dyspepsia: A Feasibility Study. Behavior Therapy 2019;50:177-88. [DOI: 10.1016/j.beth.2018.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
101 Hood MM, Wilson R, Gorenz A, Jedel S, Raeisi S, Hobfoll S, Keshavarzian A. Sleep Quality in Ulcerative Colitis: Associations with Inflammation, Psychological Distress, and Quality of Life. Int J Behav Med 2018;25:517-25. [PMID: 30159665 DOI: 10.1007/s12529-018-9745-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
102 Evans S, Seidman LC, Lung K, Sternlieb B, Zeltzer LK. Yoga for Teens With Irritable Bowel Syndrome: Results From a Mixed-Methods Pilot Study. Holist Nurs Pract 2018;32:253-60. [PMID: 30113959 DOI: 10.1097/HNP.0000000000000288] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
103 Klenzak S, Danelisen I, Brannan GD, Holland MA, van Tilburg MA. Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making. World J Clin Cases 2018; 6(15): 892-900 [PMID: 30568943 DOI: 10.12998/wjcc.v6.i15.892] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
104 Harding K, Simpson T, Kearney DJ. Reduced Symptoms of Post-Traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans. The Journal of Alternative and Complementary Medicine 2018;24:1159-65. [DOI: 10.1089/acm.2018.0135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
105 Taft TH, Kern E, Starkey K, Craft J, Craven M, Doerfler B, Keefer L, Kahrilas P, Pandolfino J. The dysphagia stress test for rapid assessment of swallowing difficulties in esophageal conditions. Neurogastroenterol Motil 2019;31:e13512. [PMID: 30474165 DOI: 10.1111/nmo.13512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Windgassen S, Moss-Morris R, Goldsmith K, Chalder T. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety. J Psychosom Res 2019;118:73-82. [PMID: 30522750 DOI: 10.1016/j.jpsychores.2018.11.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
107 Witt ST, Bednarska O, Keita ÅV, Icenhour A, Jones MP, Elsenbruch S, Söderholm JD, Engström M, Mayer EA, Walter S. Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome. Neuroimage Clin 2019;21:101602. [PMID: 30472166 DOI: 10.1016/j.nicl.2018.11.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
108 Lackner JM, Jaccard J; IBS Outcome Study Research Group. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2019;17:1500-1508.e3. [PMID: 30613000 DOI: 10.1016/j.cgh.2018.10.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
109 Farmer AD, Ruffle JK, Hobson AR. Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation. Neurogastroenterol Motil 2019;31:e13492. [PMID: 30353623 DOI: 10.1111/nmo.13492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
110 Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. Am J Gastroenterol 2018;113:1540-9. [PMID: 30254230 DOI: 10.1038/s41395-018-0262-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
111 Beath AP, Mcdonald K, Osborn TC, Jones MP. The Positive Effect of Mindfulness Rivals the Negative Effect of Neuroticism on Gastrointestinal Symptoms. Mindfulness 2019;10:712-23. [DOI: 10.1007/s12671-018-1019-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
112 Krouwel M, Greenfield S, Farley A, Ismail T, Jolly K. Factors which affect the efficacy of hypnotherapy for IBS: Protocol for a systematic review and meta-regression. European Journal of Integrative Medicine 2018;21:58-62. [DOI: 10.1016/j.eujim.2018.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Hunt MG, Wong C, Aajmain S, Dawodu I. Fecal incontinence in people with self-reported irritable bowel syndrome: Prevalence and quality of life. J Psychosom Res 2018;113:45-51. [PMID: 30190047 DOI: 10.1016/j.jpsychores.2018.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
114 Mohsenabadi H, Zanjani Z, Shabani MJ, Arj A. A randomized clinical trial of the Unified Protocol for Transdiagnostic treatment of emotional and gastrointestinal symptoms in patients with irritable bowel syndrome: evaluating efficacy and mechanism of change. J Psychosom Res 2018;113:8-15. [PMID: 30190053 DOI: 10.1016/j.jpsychores.2018.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
115 Rigby A. Transdiagnostic Approach to Food Avoidance After Bariatric Surgery: A Case Study. Clinical Case Studies 2018;17:280-95. [DOI: 10.1177/1534650118784664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
116 Kano M, Muratsubaki T, Morishita J, Kono K, Mugikura S, Takase K, Ly HG, Dupont P, Van Oudenhove L, Fukudo S. Influence of Uncertain Anticipation on Brain Responses to Aversive Rectal Distension in Patients With Irritable Bowel Syndrome. Psychosom Med 2017;79:988-99. [PMID: 28498276 DOI: 10.1097/PSY.0000000000000484] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
117 Reis DJ, Ilardi SS, Punt SEW. The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature. PLoS One 2018;13:e0199041. [PMID: 29924822 DOI: 10.1371/journal.pone.0199041] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
118 Cassar GE, Knowles S, Youssef GJ, Moulding R, Uiterwijk D, Waters L, Austin DW. Examining the mediational role of psychological flexibility, pain catastrophizing, and visceral sensitivity in the relationship between psychological distress, irritable bowel symptom frequency, and quality of life. Psychology, Health & Medicine 2017;23:1168-81. [DOI: 10.1080/13548506.2018.1476722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
119 Zweig A, Schindler V, Becker AS, van Maren A, Pohl D. Higher prevalence of joint hypermobility in constipation predominant irritable bowel syndrome.Neurogastroenterol Motil. 2018;30:e13353. [PMID: 29687534 DOI: 10.1111/nmo.13353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
120 Carrozzino D, Porcelli P. Alexithymia in Gastroenterology and Hepatology: A Systematic Review. Front Psychol 2018;9:470. [PMID: 29681874 DOI: 10.3389/fpsyg.2018.00470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
121 Zickgraf HF, Ellis JM. Initial validation of the Nine Item Avoidant/Restrictive Food Intake disorder screen (NIAS): A measure of three restrictive eating patterns. Appetite 2018;123:32-42. [DOI: 10.1016/j.appet.2017.11.111] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 14.5] [Reference Citation Analysis]
122 Bonnert M, Olén O, Bjureberg J, Lalouni M, Hedman-Lagerlöf E, Serlachius E, Ljótsson B. The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis. Behav Res Ther 2018;105:27-35. [PMID: 29614378 DOI: 10.1016/j.brat.2018.03.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
123 Henrich JF, Martin M. Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome. Br J Health Psychol 2018;23:612-29. [PMID: 29573051 DOI: 10.1111/bjhp.12307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
124 Taft TH, Triggs JR, Carlson DA, Guadagnoli L, Tomasino KN, Keefer L, Pandolfino JE. Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther 2018;47:1270-7. [PMID: 29528128 DOI: 10.1111/apt.14605] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
125 Clevers E, Tack J, Törnblom H, Ringström G, Luyckx K, Simrén M, Van Oudenhove L. Development of Irritable Bowel Syndrome Features Over a 5-year Period. Clin Gastroenterol Hepatol 2018;16:1244-1251.e1. [PMID: 29510214 DOI: 10.1016/j.cgh.2018.02.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
126 Zvolensky MJ, Bakhshaie J, Norton PJ, Smits JAJ, Buckner JD, Garey L, Manning K. Visceral sensitivity, anxiety, and smoking among treatment-seeking smokers. Addict Behav 2017;75:1-6. [PMID: 28654824 DOI: 10.1016/j.addbeh.2017.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
127 Vork L, Keszthelyi D, Mujagic Z, Kruimel JW, Leue C, Pontén I, Törnblom H, Simrén M, Albu-soda A, Aziz Q, Corsetti M, Holvoet L, Tack J, Rao SS, van Os J, Quetglas EG, Drossman DA, Masclee AAM. Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13244. [DOI: 10.1111/nmo.13244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
128 Särnholm J, Skúladóttir H, Rück C, Pedersen SS, Braunschweig F, Ljótsson B. Exposure-Based Therapy for Symptom Preoccupation in Atrial Fibrillation: An Uncontrolled Pilot Study. Behavior Therapy 2017;48:808-19. [DOI: 10.1016/j.beth.2017.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
129 Wilpart K, Törnblom H, Svedlund J, Tack JF, Simrén M, Van Oudenhove L. Coping Skills Are Associated With Gastrointestinal Symptom Severity and Somatization in Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 2017;15:1565-1571.e3. [DOI: 10.1016/j.cgh.2017.02.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
130 Zaman J, Madden VJ, Iven J, Wiech K, Weltens N, Ly HG, Vlaeyen JW, Van Oudenhove L, Van Diest I. Biased Intensity Judgements of Visceral Sensations After Learning to Fear Visceral Stimuli: A Drift Diffusion Approach. The Journal of Pain 2017;18:1197-208. [DOI: 10.1016/j.jpain.2017.04.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
131 Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome. Sci Rep 2017;7:12425. [PMID: 28963545 DOI: 10.1038/s41598-017-09635-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
132 Lalouni M, Ljótsson B, Bonnert M, Hedman-Lagerlöf E, Högström J, Serlachius E, Olén O. Internet-Delivered Cognitive Behavioral Therapy for Children With Pain-Related Functional Gastrointestinal Disorders: Feasibility Study. JMIR Ment Health 2017;4:e32. [PMID: 28798012 DOI: 10.2196/mental.7985] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
133 Pletikosić Tončić S, Tkalčić M. A Measure of Suffering in relation to Anxiety and Quality of Life in IBS Patients: Preliminary Results. Biomed Res Int 2017;2017:2387681. [PMID: 28744463 DOI: 10.1155/2017/2387681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
134 Ballou S, Keefer L. Development of the Irritable Bowel Syndrome Cognitive Affective Scale: a brief self-report measure for clinical and research settings. European Journal of Gastroenterology & Hepatology 2017;29:849-54. [DOI: 10.1097/meg.0000000000000872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
135 Grinsvall C, Törnblom H, Tack J, Van Oudenhove L, Simrén M. Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome. United European Gastroenterol J 2018;6:300-9. [PMID: 29511560 DOI: 10.1177/2050640617715851] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
136 Tayama J, Saigo T, Ogawa S, Takeoka A, Hamaguchi T, Hayashida M, Fukudo S, Shirabe S. Effect of attention bias modification on brain function and anxiety in patients with irritable bowel syndrome: A preliminary electroencephalogram and psycho-behavioral study. Neurogastroenterol Motil 2017;29. [PMID: 28612504 DOI: 10.1111/nmo.13131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Icenhour A, Witt ST, Elsenbruch S, Lowén M, Engström M, Tillisch K, Mayer EA, Walter S. Brain functional connectivity is associated with visceral sensitivity in women with Irritable Bowel Syndrome. Neuroimage Clin 2017;15:449-57. [PMID: 28649489 DOI: 10.1016/j.nicl.2017.06.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
138 Windgassen S, Moss-morris R, Chilcot J, Sibelli A, Goldsmith K, Chalder T. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. Br J Health Psychol 2017;22:701-36. [DOI: 10.1111/bjhp.12250] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
139 Gillanders D, Ferreira NB, Angioni E, Carvalho SA, Eugenicos MP. An implementation trial of ACT-based bibliotherapy for irritable bowel syndrome. Journal of Contextual Behavioral Science 2017;6:172-7. [DOI: 10.1016/j.jcbs.2017.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
140 Gupta A, Cole S, Labus JS, Joshi S, Nguyen TJ, Kilpatrick LA, Tillisch K, Naliboff BD, Chang L, Mayer EA. Gene expression profiles in peripheral blood mononuclear cells correlate with salience network activity in chronic visceral pain: A pilot study. Neurogastroenterol Motil 2017;29. [PMID: 28191693 DOI: 10.1111/nmo.13027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
141 Edebol-Carlman H, Ljótsson B, Linton SJ, Boersma K, Schrooten M, Repsilber D, Brummer RJ. Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms. Gastroenterol Res Pract 2017;2017:8915872. [PMID: 28210270 DOI: 10.1155/2017/8915872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
142 Bonnert M, Olén O, Lalouni M, Benninga MA, Bottai M, Engelbrektsson J, Hedman E, Lenhard F, Melin B, Simrén M, Vigerland S, Serlachius E, Ljótsson B. Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial. American Journal of Gastroenterology 2017;112:152-62. [DOI: 10.1038/ajg.2016.503] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 11.2] [Reference Citation Analysis]
143 Lam C, Chaddock G, Marciani Laurea L, Costigan C, Cox E, Hoad C, Pritchard S, Gowland P, Spiller R. Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI. Am J Gastroenterol. 2017;112:346-355. [PMID: 27958282 DOI: 10.1038/ajg.2016.538] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
144 Porcelli P, De Carne M, Leandro G. The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome. Compr Psychiatry 2017;73:127-35. [PMID: 27940317 DOI: 10.1016/j.comppsych.2016.11.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
145 Xu XJ, Zhang YL, Liu L, Pan L, Yao SK. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study. Aliment Pharmacol Ther. 2017;45:100-114. [PMID: 27862119 DOI: 10.1111/apt.13848] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
146 Zaman J, Weltens N, Ly HG, Struyf D, Vlaeyen JW, Van den Bergh O, Wiech K, Van Oudenhove L, Van Diest I. Influence of Interoceptive Fear Learning on Visceral Perception. Psychosom Med 2016;78:248-58. [PMID: 26575858 DOI: 10.1097/PSY.0000000000000257] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
147 Ballou S, Keefer L. The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS. Neurogastroenterol Motil 2017;29. [PMID: 27781332 DOI: 10.1111/nmo.12982] [Cited by in Crossref: 24] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
148 Lalouni M, Olén O, Bonnert M, Hedman E, Serlachius E, Ljótsson B. Exposure-Based Cognitive Behavior Therapy for Children with Abdominal Pain: A Pilot Trial. PLoS One 2016;11:e0164647. [PMID: 27736943 DOI: 10.1371/journal.pone.0164647] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
149 Reddy CA, Patel A, Gyawali CP. Impact of symptom burden and health-related quality of life (HRQOL) on esophageal motor diagnoses. Neurogastroenterol Motil 2017;29. [PMID: 27723241 DOI: 10.1111/nmo.12970] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
150 Orand A, Naliboff B, Gadd M, Shih W, Ju T, Presson AP, Mayer EA, Chang L. Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response. Psychoneuroendocrinology 2016;73:133-41. [PMID: 27497153 DOI: 10.1016/j.psyneuen.2016.07.204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
151 Taft TH, Riehl M, Sodikoff JB, Kahrilas PJ, Keefer L, Doerfler B, Pandolfino JE. Development and validation of the brief esophageal dysphagia questionnaire. Neurogastroenterol Motil. 2016;28:1854-1860. [PMID: 27380834 DOI: 10.1111/nmo.12889] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
152 Boeckxstaens GE, Drug V, Dumitrascu D, Farmer AD, Hammer J, Hausken T, Niesler B, Pohl D, Pojskic L, Polster A, Simren M, Goebel-Stengel M, Van Oudenhove L, Vassallo M, Wensaas KA, Aziz Q, Houghton LA; COST Action BM1106 GENIEUR members. Phenotyping of subjects for large scale studies on patients with IBS. Neurogastroenterol Motil 2016;28:1134-47. [PMID: 27319981 DOI: 10.1111/nmo.12886] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
153 Patel A, Hasak S, Cassell B, Ciorba MA, Vivio EE, Kumar M, Gyawali CP, Sayuk GS. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:246-58. [PMID: 27240555 DOI: 10.1111/apt.13677] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
154 Ceunen E, Zaman J, Weltens N, Sarafanova E, Arijs V, Vlaeyen JW, Van Oudenhove L, Van Diest I. Learned Fear of Gastrointestinal Sensations in Healthy Adults. Clin Gastroenterol Hepatol 2016;14:1552-1558.e2. [PMID: 27155550 DOI: 10.1016/j.cgh.2016.04.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
155 Rubio A, Pellissier S, Van Oudenhove L, Ly HG, Dupont P, Tack J, Dantzer C, Delon-martin C, Bonaz B. Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI study. Neurogastroenterol Motil 2016;28:1419-32. [DOI: 10.1111/nmo.12844] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
156 Pombo N, Garcia N, Bousson K, Spinsante S, Chorbev I. Pain Assessment--Can it be Done with a Computerised System? A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2016;13:415. [PMID: 27089351 DOI: 10.3390/ijerph13040415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
157 Park SH, Videlock EJ, Shih W, Presson AP, Mayer EA, Chang L. Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity. Neurogastroenterol Motil 2016;28:1252-60. [PMID: 27061107 DOI: 10.1111/nmo.12826] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
158 Knowles SR, Austin DW, Sivanesan S, Tye-Din J, Leung C, Wilson J, Castle D, Kamm MA, Macrae F, Hebbard G. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness. Psychol Health Med. 2017;22:524-534. [PMID: 27045996 DOI: 10.1080/13548506.2016.1168932] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
159 Mogoaşe C, David D, Dumitraşcu DL. Irrational Beliefs and Attention Bias Towards Symptoms-Related Stimuli in Maintaining Gastrointestinal Symptoms: Results from a Pilot Study. J Rat-Emo Cognitive-Behav Ther 2016;34:100-13. [DOI: 10.1007/s10942-015-0226-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
160 Mayer EA, Gupta A, Kilpatrick LA, Hong JY. Imaging brain mechanisms in chronic visceral pain. Pain 2015;156 Suppl 1:S50-63. [PMID: 25789437 DOI: 10.1097/j.pain.0000000000000106] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 11.0] [Reference Citation Analysis]
161 Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M. Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology 2015;149:1399-1407.e2. [DOI: 10.1053/j.gastro.2015.07.054] [Cited by in Crossref: 300] [Cited by in F6Publishing: 313] [Article Influence: 42.9] [Reference Citation Analysis]
162 Tack J, Ly HG, Carbone F, Vanheel H, Vanuytsel T, Holvoet L, Boeckxstaens G, Caenepeel P, Arts J, Van Oudenhove L. Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss. Clin Gastroenterol Hepatol. 2016;14:385-392.e4. [PMID: 26538208 DOI: 10.1016/j.cgh.2015.09.043] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 14.1] [Reference Citation Analysis]
163 Le Nevé B, Brazeilles R, Derrien M, Tap J, Guyonnet D, Ohman L, Törnblom H, Simrén M. Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2015; Oct 19. [Epub ahead of print]. [PMID: 26492847 DOI: 10.1016/j.cgh.2015.09.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
164 Mujagic Z, Keszthelyi D, Aziz Q, Reinisch W, Quetglas EG, De Leonardis F, Segerdahl M, Masclee AA. Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:1064-81. [PMID: 26290286 DOI: 10.1111/apt.13378] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
165 Orand A, Gupta A, Shih W, Presson AP, Hammer C, Niesler B, Heendeniya N, Mayer EA, Chang L. Catecholaminergic Gene Polymorphisms Are Associated with GI Symptoms and Morphological Brain Changes in Irritable Bowel Syndrome. PLoS One 2015;10:e0135910. [PMID: 26288143 DOI: 10.1371/journal.pone.0135910] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
166 Krarup AL, Peterson E, Ringström G, Törnblom H, Hjortswang H, Simrén M. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2015;49:565-70. [DOI: 10.1097/mcg.0000000000000209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
167 Hubbard CS, Hong J, Jiang Z, Ebrat B, Suyenobu B, Smith S, Heendeniya N, Naliboff BD, Tillisch K, Mayer EA, Labus JS. Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome. Neurogastroenterol Motil 2015;27:1282-94. [PMID: 26087779 DOI: 10.1111/nmo.12622] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
168 Shahabi L, Naliboff BD, Shapiro D. Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study. Psychol Health Med 2016;21:176-88. [PMID: 26086986 DOI: 10.1080/13548506.2015.1051557] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
169 Dainese R, Casellas F, Mariné-Barjoan E, Vivinus-Nébot M, Schneider SM, Hébuterne X, Piche T. Perception of lactose intolerance in irritable bowel syndrome patients. Eur J Gastroenterol Hepatol. 2014;26:1167-1175. [PMID: 25089542 DOI: 10.1097/meg.0000000000000089] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
170 Zaman J, Vlaeyen JW, Van Oudenhove L, Wiech K, Van Diest I. Associative fear learning and perceptual discrimination: A perceptual pathway in the development of chronic pain. Neuroscience & Biobehavioral Reviews 2015;51:118-25. [DOI: 10.1016/j.neubiorev.2015.01.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 9.4] [Reference Citation Analysis]
171 Riehl ME, Pandolfino JE, Palsson OS, Keefer L. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn. Dis Esophagus 2016;29:490-6. [PMID: 25824436 DOI: 10.1111/dote.12353] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
172 Björkman I, Jakobsson Ung E, Ringström G, Törnblom H, Simrén M. More similarities than differences between men and women with irritable bowel syndrome. Neurogastroenterol Motil 2015;27:796-804. [PMID: 25817301 DOI: 10.1111/nmo.12551] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
173 Hong JY, Kilpatrick LA, Labus JS, Gupta A, Katibian D, Ashe-McNalley C, Stains J, Heendeniya N, Smith SR, Tillisch K. Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain. J Neurosci. 2014;34:14252-14259. [PMID: 25339739 DOI: 10.1523/jneurosci.1683-14.2014] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
174 Hunt MG, Ertel E, Coello JA, Rodriguez L. Empirical Support for a Self-help Treatment for IBS. Cogn Ther Res 2015;39:215-27. [DOI: 10.1007/s10608-014-9647-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
175 Tkalcic M, Domijan D, Pletikosic S, Setic M, Hauser G. Attentional biases in irritable bowel syndrome patients. Clinics and Research in Hepatology and Gastroenterology 2014;38:621-8. [DOI: 10.1016/j.clinre.2014.02.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
176 Lackner JM, Gudleski GD, Ma CX, Dewanwala A, Naliboff B; Representing the IBSOS Outcome Study Research Group. Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS. Am J Gastroenterol 2014;109:1815-23. [PMID: 25223577 DOI: 10.1038/ajg.2014.241] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
177 Spiegel BM, Hays RD, Bolus R, Melmed GY, Chang L, Whitman C, Khanna PP, Paz SH, Hays T, Reise S, Khanna D. Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol 2014;109:1804-14. [PMID: 25199473 DOI: 10.1038/ajg.2014.237] [Cited by in Crossref: 111] [Cited by in F6Publishing: 120] [Article Influence: 13.9] [Reference Citation Analysis]
178 Lorenzo-Zúñiga V, Llop E, Suárez C, Álvarez B, Abreu L, Espadaler J, Serra J. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 2014; 20(26): 8709-8716 [PMID: 25024629 DOI: 10.3748/wjg.v20.i26.8709] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
179 Bonnert M, Ljótsson B, Hedman E, Andersson J, Arnell H, Benninga MA, Simrén M, Thulin H, Thulin U, Vigerland S, Serlachius E, Olén O. Internet-delivered cognitive behavior therapy for adolescents with functional gastrointestinal disorders — An open trial. Internet Interventions 2014;1:141-8. [DOI: 10.1016/j.invent.2014.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
180 Hauser G, Pletikosic S, Tkalcic M. Cognitive behavioral approach to understanding irritable bowel syndrome. World J Gastroenterol 2014; 20(22): 6744-6758 [PMID: 24944466 DOI: 10.3748/wjg.v20.i22.6744] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
181 Ludidi S, Mujagic Z, Jonkers D, Keszthelyi D, Hesselink M, Kruimel J, Conchillo J, Masclee A. Markers for visceral hypersensitivity in patients with irritable bowel syndrome. Neurogastroenterol Motil 2014;26:1104-11. [PMID: 24920528 DOI: 10.1111/nmo.12365] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
182 Porcelli P, De Carne M, Leandro G. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Compr Psychiatry. 2014;55:1647-1653. [PMID: 25011689 DOI: 10.1016/j.comppsych.2014.05.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
183 Rubio A, Pellissier S, Picot A, Dantzer C, Bonaz B. The link between negative affect, vagal tone, and visceral sensitivity in quiescent Crohn's disease. Neurogastroenterol Motil 2014;26:1200-3. [PMID: 24861415 DOI: 10.1111/nmo.12373] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
184 Cohen E, Bolus R, Khanna D, Hays RD, Chang L, Melmed GY, Khanna P, Spiegel B. GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci. 2014;59:2488-2496. [PMID: 24811245 DOI: 10.1007/s10620-014-3181-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
185 Ljótsson B, Hesser H, Andersson E, Lackner JM, El Alaoui S, Falk L, Aspvall K, Fransson J, Hammarlund K, Löfström A, Nowinski S, Lindfors P, Hedman E. Provoking symptoms to relieve symptoms: A randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behaviour Research and Therapy 2014;55:27-39. [DOI: 10.1016/j.brat.2014.01.007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 8.6] [Reference Citation Analysis]
186 Saigo T, Tayama J, Hamaguchi T, Nakaya N, Tomiie T, Bernick PJ, Kanazawa M, Labus JS, Naliboff BD, Shirabe S, Fukudo S. Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students. Biopsychosoc Med. 2014;8:10. [PMID: 24655428 DOI: 10.1186/1751-0759-8-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
187 Hunt MG, Ertel E, Coello JA, Rodriguez L. Development and Validation of the GI-Cognitions Questionnaire. Cogn Ther Res 2014;38:472-82. [DOI: 10.1007/s10608-014-9607-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
188 Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita ÅV, Pardon N, Santos J, Söderholm JD, Tack J, Farré R. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014;63:262-71. [PMID: 23474421 DOI: 10.1136/gutjnl-2012-303857] [Cited by in Crossref: 245] [Cited by in F6Publishing: 220] [Article Influence: 30.6] [Reference Citation Analysis]
189 Lackner JM, Gudleski GD, Thakur ER, Stewart TJ, Iacobucci GJ, Spiegel BM. The impact of physical complaints, social environment, and psychological functioning on IBS patients’ health perceptions: looking beyond GI symptom severity. Am J Gastroenterol. 2014;109:224-233. [PMID: 24419481 DOI: 10.1038/ajg.2013.410] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
190 Hong JY, Labus JS, Jiang Z, Ashe-Mcnalley C, Dinov I, Gupta A, Shi Y, Stains J, Heendeniya N, Smith SR. Regional neuroplastic brain changes in patients with chronic inflammatory and non-inflammatory visceral pain. PLoS One. 2014;9:e84564. [PMID: 24416245 DOI: 10.1371/journal.pone.0084564] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
191 Khanna P, Agarwal N, Khanna D, Hays RD, Chang L, Bolus R, Melmed G, Whitman CB, Kaplan RM, Ogawa R, Snyder B, Spiegel BM. Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. Am J Gastroenterol 2014;109:234-48. [PMID: 24343547 DOI: 10.1038/ajg.2013.401] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
192 Ljótsson B, Andersson E, Lindfors P, Lackner JM, Grönberg K, Molin K, Norén J, Romberg K, Andersson E, Hursti T, Hesser H, Hedman E. Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. BMC Gastroenterol 2013;13:160. [PMID: 24245807 DOI: 10.1186/1471-230X-13-160] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
193 McKinnon AC, Van Oudenhove L, Tack J, Jones M. The association of personality, appraisal, catastrophising and vigilance with gastrointestinal symptom-specific anxiety. J Health Psychol. 2015;20:456-465. [PMID: 24155193 DOI: 10.1177/1359105313503027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
194 Hong JY, Kilpatrick LA, Labus J, Gupta A, Jiang Z, Ashe-McNalley C, Stains J, Heendeniya N, Ebrat B, Smith S. Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain. J Neurosci. 2013;33:11994-12002. [PMID: 23864686 DOI: 10.1523/jneurosci.5733-12.2013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 7.9] [Reference Citation Analysis]
195 Su AM, Shih W, Presson AP, Chang L. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil. 2014;26:36-45. [PMID: 23991913 DOI: 10.1111/nmo.12220] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
196 Naliboff BD, Fresé MP, Rapgay L. Mind/Body psychological treatments for irritable bowel syndrome. Evid Based Complement Alternat Med. 2008;5:41-50. [PMID: 18317547 DOI: 10.1093/ecam/nem046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
197 Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108:634-641. [PMID: 23644955 DOI: 10.1038/ajg.2013.105] [Cited by in Crossref: 293] [Cited by in F6Publishing: 307] [Article Influence: 32.6] [Reference Citation Analysis]
198 Bessissow T, Van Keerberghen CA, Van Oudenhove L, Ferrante M, Vermeire S, Rutgeerts P, Van Assche G. Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls. J Crohns Colitis. 2013;7:e580-e587. [PMID: 23664621 DOI: 10.1016/j.crohns.2013.04.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
199 Le Nevé B, Posserud I, Böhn L, Guyonnet D, Rondeau P, Tillisch K, Naliboff B, Mayer EA, Simrén M. A Combined Nutrient and Lactulose Challenge Test Allows Symptom-Based Clustering of Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 2013;108:786-95. [DOI: 10.1038/ajg.2013.75] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
200 Lowén MB, Mayer EA, Sjöberg M, Tillisch K, Naliboff B, Labus J, Lundberg P, Ström M, Engström M, Walter SA. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37:1184-1197. [PMID: 23617618 DOI: 10.1111/apt.12319] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
201 Spiegel BM. Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil 2013;19:137-48. [PMID: 23667745 DOI: 10.5056/jnm.2013.19.2.137] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
202 Lackner JM, Gudleski GD, Dimuro J, Keefer L, Brenner DM. Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome. Behav Res Ther. 2013;51:323-331. [PMID: 23578499 DOI: 10.1016/j.brat.2013.03.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
203 Ringström G, Störsrud S, Simrén M. A comparison of a short nurse-based and a long multidisciplinary version of structured patient education in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2012;24:950-957. [PMID: 22617366 DOI: 10.1097/meg.0b013e328354f41f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
204 Labus J, Gupta A, Gill HK, Posserud I, Mayer M, Raeen H, Bolus R, Simren M, Naliboff BD, Mayer EA. Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther. 2013;37:304-315. [PMID: 23205588 DOI: 10.1111/apt.12171] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
205 Ferreira NB, Eugenicos MP, Morris PG, Gillanders DT. Measuring acceptance in irritable bowel syndrome: preliminary validation of an adapted scale and construct utility. Qual Life Res 2013;22:1761-6. [DOI: 10.1007/s11136-012-0299-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
206 Berman S, Suyenobu B, Naliboff BD, Bueller J, Stains J, Wong H, Mandelkern M, Fitzgerald L, Ohning G, Gupta A. Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome. Neuroimage. 2012;63:1854-1863. [PMID: 22917679 DOI: 10.1016/j.neuroimage.2012.08.028] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
207 Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, Dunlap LJ, Ma C, Byroads M; IBSOS Research Group. The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemp Clin Trials 2012;33:1293-310. [PMID: 22846389 DOI: 10.1016/j.cct.2012.07.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
208 Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD. Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther 2012;50:647-50. [PMID: 22877888 DOI: 10.1016/j.brat.2012.05.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
209 Surdea-Blaga T, Băban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 2012; 18(7): 616-626 [PMID: 22363132 DOI: 10.3748/wjg.v18.i7.616] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 93] [Article Influence: 9.7] [Reference Citation Analysis]
210 Ohman L, Stridsberg M, Isaksson S, Jerlstad P, Simrén M. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol. 2012;107:440-447. [PMID: 22233694 DOI: 10.1038/ajg.2011.458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
211 Bradford K, Shih W, Videlock EJ, Presson AP, Naliboff BD, Mayer EA, Chang L. Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol. 2012;10:385-90.e1. [PMID: 22178460 DOI: 10.1016/j.cgh.2011.12.018] [Cited by in Crossref: 178] [Cited by in F6Publishing: 169] [Article Influence: 16.2] [Reference Citation Analysis]
212 Garland EL, Gaylord SA, Palsson O, Faurot K, Douglas Mann J, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med 2012;35:591-602. [PMID: 22161025 DOI: 10.1007/s10865-011-9391-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 109] [Article Influence: 9.0] [Reference Citation Analysis]
213 Larsson MB, Tillisch K, Craig AD, Engström M, Labus J, Naliboff B, Lundberg P, Ström M, Mayer EA, Walter SA. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology. 2012;142:463-472.e3. [PMID: 22108191 DOI: 10.1053/j.gastro.2011.11.022] [Cited by in Crossref: 108] [Cited by in F6Publishing: 112] [Article Influence: 9.8] [Reference Citation Analysis]
214 Ljótsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andréewitch S, Rück C, Lindefors N. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol. 2011;11:110. [PMID: 21992655 DOI: 10.1186/1471-230x-11-110] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
215 Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, Leniek K, Whitehead WE. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol. 2011;106:1678-1688. [PMID: 21691341 DOI: 10.1038/ajg.2011.184] [Cited by in Crossref: 149] [Cited by in F6Publishing: 151] [Article Influence: 13.5] [Reference Citation Analysis]
216 Kearney DJ, McDermott K, Martinez M, Simpson TL. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life. Aliment Pharmacol Ther. 2011;34:363-373. [PMID: 21651595 DOI: 10.1111/j.1365-2036.2011.04731.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
217 Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381-396. [PMID: 21090962 DOI: 10.1146/annurev-med-012309-103958] [Cited by in Crossref: 275] [Cited by in F6Publishing: 263] [Article Influence: 25.0] [Reference Citation Analysis]
218 Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, Rydh S, Rück C, Lindefors N, Andersson G. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011;106:1481-1491. [PMID: 21537360 DOI: 10.1038/ajg.2011.139] [Cited by in Crossref: 132] [Cited by in F6Publishing: 126] [Article Influence: 12.0] [Reference Citation Analysis]
219 Spiegel BM, Khanna D, Bolus R, Agarwal N, Khanna P, Chang L. Understanding gastrointestinal distress: a framework for clinical practice. Am J Gastroenterol 2011;106:380-5. [PMID: 21378758 DOI: 10.1038/ajg.2010.383] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
220 Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49:413-421. [PMID: 21565328 DOI: 10.1016/jbrat.2011.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49:413-421. [PMID: 21565328 DOI: 10.1016/j.brat.2011.04.001] [Cited by in Crossref: 146] [Cited by in F6Publishing: 141] [Article Influence: 13.3] [Reference Citation Analysis]
222 Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, Bueller JA, Suyenobu B, Jarcho JM, McRoberts JA, Niesler B, Mayer EA. The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology. 2011;140:1943-1951. [PMID: 21420406 DOI: 10.1053/j.gastro.2011.03.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
223 Evans S, Cousins L, Tsao JC, Sternlieb B, Zeltzer LK. Protocol for a randomized controlled study of Iyengar yoga for youth with irritable bowel syndrome. Trials 2011;12:15. [PMID: 21244698 DOI: 10.1186/1745-6215-12-15] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
224 Lind R, Lied GA, Lillestøl K, Valeur J, Berstad A. Do psychological factors predict symptom severity in patients with subjective food hypersensitivity? Scand J Gastroenterol 2010;45:835-43. [PMID: 20433401 DOI: 10.3109/00365521003797213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
225 Ljótsson B, Hedman E, Lindfors P, Hursti T, Lindefors N, Andersson G, Rück C. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther. 2011;49:58-61. [PMID: 21092934 DOI: 10.1016/j.brat.2010.10.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
226 Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S, Esrailian E, Chey WD, Lembo A, Karsan H, Tillisch K, Talley J, Chang L. Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Aliment Pharmacol Ther 2010;32:1275-91. [PMID: 20955447 DOI: 10.1111/j.1365-2036.2010.04464.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
227 Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N. Exposure and mindfulness based therapy for irritable bowel syndrome – An open pilot study. Journal of Behavior Therapy and Experimental Psychiatry 2010;41:185-90. [DOI: 10.1016/j.jbtep.2010.01.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
228 Spiegel BM, Bolus R, Harris LA, Lucak S, Chey WD, Sayuk G, Esrailian E, Lembo A, Karsan H, Tillisch K. Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice. Aliment Pharmacol Ther. 2010;32:1192-1202. [PMID: 20807217 DOI: 10.1111/j.1365-2036.2010.04443.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
229 Keough ME, Timpano KR, Zawilinski LL, Schmidt NB. The association between irritable bowel syndrome and the anxiety vulnerability factors: body vigilance and discomfort intolerance. J Health Psychol. 2011;16:91-98. [PMID: 20631041 DOI: 10.1177/1359105310367689] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
230 Ringström G, Störsrud S, Posserud I, Lundqvist S, Westman B, Simrén M. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study. Eur J Gastroenterol Hepatol 2010;22:420-8. [PMID: 19923998 DOI: 10.1097/MEG.0b013e3283333b61] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
231 Carruthers HR, Morris J, Tarrier N, Whorwell PJ. Reactivity to images in health and irritable bowel syndrome. Aliment Pharmacol Ther 2010;31:131-42. [PMID: 19744134 DOI: 10.1111/j.1365-2036.2009.04143.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
232 Chang L, Drossman DA. Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID. American Journal of Gastroenterology 2010;105:722-30. [DOI: 10.1038/ajg.2010.49] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
233 Jerndal P, Ringström G, Agerforz P, Karpefors M, Akkermans LM, Bayati A, Simrén M. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil. 2010;22:646-e179. [PMID: 20367800 DOI: 10.1111/j.1365-2982.2010.01493.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 103] [Article Influence: 7.5] [Reference Citation Analysis]
234 Ljótsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Rück C, Hursti T, Andréewitch S, Jansson L, Lindefors N. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behav Res Ther. 2010;48:531-539. [PMID: 20362976 DOI: 10.1016/j.brat.2010.03.003] [Cited by in Crossref: 148] [Cited by in F6Publishing: 142] [Article Influence: 12.3] [Reference Citation Analysis]
235 Mayer EA, Aziz Q, Coen S, Kern M, Labus JS, Lane R, Kuo B, Naliboff B, Tracey I. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol Motil. 2009;21:579-596. [PMID: 19646070 DOI: 10.1111/j.1365-2982.2009.01304.x] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 11.1] [Reference Citation Analysis]
236 Spiegel B, Bolus R, Harris LA, Lucak S, Naliboff B, Esrailian E, Chey WD, Lembo A, Karsan H, Tillisch K, Talley J, Mayer E, Chang L. Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther 2009;30:1159-70. [PMID: 19751360 DOI: 10.1111/j.1365-2036.2009.04144.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
237 Hunt MG, Moshier S, Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behaviour Research and Therapy 2009;47:797-802. [DOI: 10.1016/j.brat.2009.05.002] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 6.8] [Reference Citation Analysis]
238 Spiegel B, Harris L, Lucak S, Mayer E, Naliboff B, Bolus R, Esrailian E, Chey WD, Lembo A, Karsan H, Tillisch K, Dulai G, Talley J, Chang L. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. Am J Gastroenterol 2009;104:1984-91. [PMID: 19491835 DOI: 10.1038/ajg.2009.232] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
239 Gaylord SA, Whitehead WE, Coble RS, Faurot KR, Palsson OS, Garland EL, Frey W, Mann JD. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement Altern Med 2009;9:24. [PMID: 19638214 DOI: 10.1186/1472-6882-9-24] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
240 Ringström G, Abrahamsson H, Strid H, Simrén M. Why do subjects with irritable bowel syndrome seek health care for their symptoms? Scandinavian Journal of Gastroenterology 2009;42:1194-203. [DOI: 10.1080/00365520701320455] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
241 Posserud I, Svedlund J, Wallin J, Simrén M. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease. Journal of Psychosomatic Research 2009;66:399-405. [DOI: 10.1016/j.jpsychores.2008.09.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
242 Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome. Am J Gastroenterol 2008;103:2562-9. [PMID: 18775020 DOI: 10.1111/j.1572-0241.2008.02115.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
243 Kearney DJ, Brown-Chang J. Complementary and alternative medicine for IBS in adults: mind-body interventions. Nat Clin Pract Gastroenterol Hepatol. 2008;5:624-636. [PMID: 18825145 DOI: 10.1038/ncpgasthep1257] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
244 Videlock EJ, Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin North Am. 2007;36:665-685, x. [PMID: 17950443 DOI: 10.1016/j.gtc.2007.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
245 Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M. Altered Rectal Perception in Irritable Bowel Syndrome Is Associated With Symptom Severity. Gastroenterology 2007;133:1113-23. [DOI: 10.1053/j.gastro.2007.07.024] [Cited by in Crossref: 175] [Cited by in F6Publishing: 180] [Article Influence: 11.7] [Reference Citation Analysis]
246 Van Oudenhove L, Coen SJ, Aziz Q. Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol 2007; 13(25): 3438-3445 [PMID: 17659690 DOI: 10.3748/wjg.v13.i25.3438] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
247 Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Persoons P, Demyttenaere K, Fischler B, Tack J. Relationship Between Anxiety and Gastric Sensorimotor Function in Functional Dyspepsia. Psychosomatic Medicine 2007;69:455-63. [DOI: 10.1097/psy.0b013e3180600a4a] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
248 Anand P, Aziz Q, Willert R, van Oudenhove L. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil. 2007;19:29-46. [PMID: 17280584 DOI: 10.1111/j.1365-2982.2006.00873.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 133] [Article Influence: 8.9] [Reference Citation Analysis]
249 Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med. 2007;69:89-98. [PMID: 17244851 DOI: 10.1097/psy.0b013e31802e2f24] [Cited by in Crossref: 143] [Cited by in F6Publishing: 154] [Article Influence: 9.5] [Reference Citation Analysis]
250 Afzal M, Potokar JP, Probert CSJ, Munafò MR. Selective Processing of Gastrointestinal Symptom-related Stimuli in Irritable Bowel Syndrome. Psychosomatic Medicine 2006;68:758-61. [DOI: 10.1097/01.psy.0000232270.78071.28] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
251 Hinton DE, Chhean D, Fama JM, Pollack MH, McNally RJ. Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. J Anxiety Disord 2007;21:42-58. [PMID: 16650726 DOI: 10.1016/j.janxdis.2006.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
252 Longstreth GF, Bolus R, Naliboff B, Chang L, Kulich KR, Carlsson J, Mayer EA, Naesdal J, Wiklund IK. Impact of irritable bowel syndrome on patients’ lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol. 2005;17:411-420. [PMID: 15756093 DOI: 10.1097/00042737-200504000-00004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]